Nuclear receptors and liver disease (the Part 2)

1. Alvaro D., Barbaro B., Franchitto A. et al. Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma // Am. J. Pathol. – 2006. – Vol. 169, N 3. – P. 877–888.

2. Donthamsetty S., Bhave V.S., Mitra M.S. et al. Nonalcoholic steatohepatitic (NASH) mice are protected from higher hepatotoxicity of acetaminophen upon induction of PPARalpha with clofibrate // Toxicol. Appl. Pharmacol. – 2008. – Vol. 230, N 3. – P. 327– 337.

3. Elfaki D.A.H., Bjornsson E., Lindor K.D. Nuclear receptors and liver disease – current understanding and new therapeutic implications // Aliment. Pharmacol. Ther. – 2009. – Vol. 30, N 8. – P. 816–825.

4. Eloranta J.J., Kullak-Ublick G.A. The role of FXR in disorders of bile acid homeostasis // Physiology. – 2008. – Vol. 23. – P. 286–295.

5. Gui C., Miao Y., Thompson L. et al. Effect of PXR ligands on transport mediated by human OATP1B1 and OATP1B3 // Eur. J. Pharmacol. – 2008. – Vol. 584. – P. 57–65.

6. Hubbert M.L., Zhang Y., Lee F.Y., Edwards P.A. Regulation of hepatic insig-2 by the farnesoid X receptor // Mol. Endocrinol. – 2007. – Vol. 21. – P. 1359– 1369.

7. Klein K., Kullak-Ublick G.A., Wagner M. et al. Hepatocyte nuclear factor-4α and bile acids regulate human concentrative nucleoside transporter-1 gene expression // J. Physiol. Gastrointest. Liver Physiol. – 2009. – Vol. 296. – P. 936–947.

8. Lefebvre P., Cariou B., Lien F. et al. Role of bile acids and bile acid receptors in metabolic regulation // Physiol. Rev. – 2009. – Vol. 89. – P. 147–191.

9. Mancino A., Mancino M.G., Glaser S.S. et al. Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor // Dig. Liver Dis. – 2009. – Vol. 41, N 2. – P. 156–163.

10. Meng Z., Wang Y., Wang L. et al. FXR regulates liver repair after CCl4-induced toxic injury // Mol. Endocrinol. – 2010. – Vol. 24. – P. 886–897.

11. Ramiиre C., Scholtиs C., Diaz O. et al. Transactivation of the hepatitis B virus core promoter by the nuclear receptor FXRalpha // J. Virol. – 2008. – Vol. 82, N 21. – P. 10832–10840.

12. Scholtes C., Diaz O., Icard V. et al. Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR // J. Hepatol. – 2008. – Vol. 48, N 2. – P. 192–199.

13. Teng S., Piquette-Miller M. Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis // Br. J. Pharmacol. – 2007. – Vol. 151, N 3. – P. 367–376.

14. Uppal H., Saini S.P., Moschetta A. et al. Activation of LXRs prevents bile acid toxicity and cholestasis in female mice // Hepatology. – 2007. – Vol. 45, N 2. – P. 422–432.

15. Yang F., Huang X., Yi T. et al. Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor // Cancer Res. – 2007. – Vol. 67. – P. 863–867.

16. Yusuke Inoue, Ai-Ming Yu, Sun Hee Yim et al. Regulation of bile acid biosynthesis by hepatocyte nuclear factor 4α // J. Lipid Res. – 2006. – Vol. 47. – P. 215– 227.

17. Zhang J., Huang W., Qatanani M. et al. The constitutive androstane receptor and pregnane X receptor function coordinately to prevent bile acid-induced hepatotoxicity // J. Biol. Chem. – 2004. – Vol. 279, N 47. – P. 49517–49522.